指南与共识前列腺癌

临床局限性前列腺癌:AUA/ASTRO指南第三部分:放射治疗原则与未来方向

Clinically Localized Prostate Cancer: AUA/ASTRO Guideline. Part III: Principles of Radiation and Future Directions.
指南 / 共识 · J Urol · 2022-05-10

本指南为AUA/ASTRO临床局限性前列腺癌指南三部分系列的第三部分,阐述放射治疗原则并提出未来研究方向。指南基于独立方法学顾问实施的系统综述,由研究馆员检索Ovid MEDLINE、Cochrane对照试验中心注册库和Cochrane系统综述数据库,并结合既往AUA综述纳入的研究及参考文献列表补充检索。专家组据此制定基于证据和共识的指南声明,以协助临床医生管理临床局限性前列腺癌患者。

要点

  • 本部分阐述临床局限性前列腺癌的放射治疗原则及未来研究方向。
  • 指南声明基于系统综述证据与专家组共识制定。
  • 未来试验的高质量证据对进一步改善患者照护至关重要。

核心结论

  • 本指南旨在为治疗临床局限性前列腺癌患者的临床医生提供信息。
  • 未来试验持续产出并发表高质量证据,对进一步改善这些男性的照护至关重要。

研究设计与样本

  • 本指南为AUA/ASTRO临床局限性前列腺癌指南三部分系列的第三部分。
  • 系统综述由独立方法学顾问实施,研究馆员检索Ovid MEDLINE、Cochrane对照试验中心注册库和Cochrane系统综述数据库。
  • 方法学团队以既往AUA综述纳入的研究及相关文章参考文献列表补充电子数据库检索。
  • 临床局限性前列腺癌专家组制定基于证据和共识的指南声明。

主要发现

  • 专家组就放射治疗管理患者及重要未来研究方向制定指南声明,详见本部分。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The summary presented herein represents Part III of the three-part series dedicated to Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, discussing principles of radiation and offering several future directions of further relevant study in patients diagnosed with clinically localized prostate cancer. Please refer to Parts I and II for discussion of risk assessment, staging, and risk-based management (Part I), and principles of active surveillance and surgery and follow-up (Part II). MATERIALS AND METHODS: The systematic review utilized to inform this guideline was conducted by an independent methodological consultant. A research librarian conducted searches in Ovid MEDLINE, Cochrane Central Register of Controlled Trials, and Cochrane Database of Systematic Reviews. The methodology team supplemented searches of electronic databases with the studies included in the prior AUA review and by reviewing reference lists of relevant articles. RESULTS: The Clinically Localized Prostate Cancer Panel created evidence- and consensus-based guideline statements to aid clinicians in the management of patients with clinically localized prostate cancer. Statements regarding management of patients using radiation therapy as well as important future directions of research are detailed herein. CONCLUSIONS: This guideline aims to inform clinicians treating patients with clinically localized prostate cancer. Continued research and publication of high-quality evidence from future trials will be essential to further improve care for these men.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Eastham JA, Auffenberg GB, Barocas DA, et al. Clinically Localized Prostate Cancer: AUA/ASTRO Guideline. Part III: Principles of Radiation and Future Directions. J Urol. 2022. PMID: 35536141. doi:10.1097/JU.0000000000002759

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。